Executive summary

This study reported clinical outcomes of 68 patients with major salivary gland tumors including the parotid gland (75.0%) and adenoid cystic carcinoma (22.1%) treated by PBT. The 3-year rates of locoregional control, progression-free survival, and overall survival were 95.1%, 80.7%, and 96.1%. This study concluded that the rates of locoregional were high in short-term follow-up. 

Key content topics
Top cancer treatments